Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yee Sin Leo

Showing results (271-280 of 328) with videos related to

Pageof 33
Sort By:
Antimicrobial Resistance and Infection Control|August 13, 2021
Nosocomial infections among COVID-19 patients: an analysis of intensive care unit surveillance dataClara Chong Hui Ong, Sharifah Farhanah, Kyaw Zaw Linn, et al.
EMBO Molecular Medicine|December 3, 2014
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody responseZhisheng Her, Terk-Shin Teng, Jeslin J L Tan, et al.
Plos Neglected Tropical Diseases|June 30, 2012
Prophylactic platelets in dengue: survey responses highlight lack of an evidence baseJames Whitehorn, Rosmari Rodriguez Roche, Maria G Guzman, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 26, 2021
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort studyPo Ying Chia, Sean Wei Xiang Ong, Calvin J Chiew, et al.
The Lancet Regional Health. Western Pacific|November 8, 2021
Impact of Delta Variant and Vaccination on SARS-CoV-2 Secondary Attack Rate Among Household Close ContactsOon Tek Ng, Vanessa Koh, Calvin J Chiew, et al.
EMBO Molecular Medicine|March 6, 2012
Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoproteinYiu-Wing Kam, Fok-Moon Lum, Teck-Hui Teo, et al.
JAMA|April 15, 2010
2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in SingaporeMark I C Chen, Vernon J M Lee, Wei-Yen Lim, et al.
The Journal of Infectious Diseases|April 20, 2018
Longitudinal Study of Cellular and Systemic Cytokine Signatures to Define the Dynamics of a Balanced Immune Environment During Disease Manifestation in Zika Virus-Infected PatientsFok-Moon Lum, David C B Lye, Jeslin J L Tan, et al.
Clinical & Translational Immunology|November 12, 2019
Immunological observations and transcriptomic analysis of trimester-specific full-term placentas from three Zika virus-infected womenFok-Moon Lum, Vipin Narang, Susan Hue, et al.
BMJ (Clinical Research Ed.)|August 1, 2020
Remdesivir for severe covid-19: a clinical practice guidelineBram Rochwerg, Arnav Agarwal, Linan Zeng, et al.
Pageof 33

Showing results (271-280 of 328) with videos related to

Sort By:
Pageof 33
Antimicrobial Resistance and Infection Control|August 13, 2021
Nosocomial infections among COVID-19 patients: an analysis of intensive care unit surveillance dataClara Chong Hui Ong, Sharifah Farhanah, Kyaw Zaw Linn, et al.
EMBO Molecular Medicine|December 3, 2014
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody responseZhisheng Her, Terk-Shin Teng, Jeslin J L Tan, et al.
Plos Neglected Tropical Diseases|June 30, 2012
Prophylactic platelets in dengue: survey responses highlight lack of an evidence baseJames Whitehorn, Rosmari Rodriguez Roche, Maria G Guzman, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 26, 2021
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort studyPo Ying Chia, Sean Wei Xiang Ong, Calvin J Chiew, et al.
The Lancet Regional Health. Western Pacific|November 8, 2021
Impact of Delta Variant and Vaccination on SARS-CoV-2 Secondary Attack Rate Among Household Close ContactsOon Tek Ng, Vanessa Koh, Calvin J Chiew, et al.
EMBO Molecular Medicine|March 6, 2012
Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoproteinYiu-Wing Kam, Fok-Moon Lum, Teck-Hui Teo, et al.
JAMA|April 15, 2010
2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in SingaporeMark I C Chen, Vernon J M Lee, Wei-Yen Lim, et al.
The Journal of Infectious Diseases|April 20, 2018
Longitudinal Study of Cellular and Systemic Cytokine Signatures to Define the Dynamics of a Balanced Immune Environment During Disease Manifestation in Zika Virus-Infected PatientsFok-Moon Lum, David C B Lye, Jeslin J L Tan, et al.
Clinical & Translational Immunology|November 12, 2019
Immunological observations and transcriptomic analysis of trimester-specific full-term placentas from three Zika virus-infected womenFok-Moon Lum, Vipin Narang, Susan Hue, et al.
BMJ (Clinical Research Ed.)|August 1, 2020
Remdesivir for severe covid-19: a clinical practice guidelineBram Rochwerg, Arnav Agarwal, Linan Zeng, et al.
Pageof 33